Last reviewed · How we verify
Neural Stem Cells
At a glance
| Generic name | Neural Stem Cells |
|---|---|
| Sponsor | Gary Steinberg, MD, PhD |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas (PHASE1)
- Expansion Study of ALT001 in Patients With Multiple System Atrophy (EARLY_PHASE1)
- Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation (NA)
- Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss (EARLY_PHASE1)
- First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant (PHASE1, PHASE2)
- Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial (NA)
- Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial (NA)
- Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Neural Stem Cells CI brief — competitive landscape report
- Neural Stem Cells updates RSS · CI watch RSS
- Gary Steinberg, MD, PhD portfolio CI